ATC code none PubChem CID 9577221 ChemSpider 7851660 Molar mass 449.582 g/mol | CAS Number 199396-76-4 IUPHAR/BPS 2883 UNII 72W09924WP | |
 | ||
How to pronounce asoprisnil
Asoprisnil (J867) is an investigational selective progesterone-receptor modulator developed by Schering and TAP Pharmaceutical Products, tested for treatment of progesterone-sensitive myomata.
In 2005, phase-III trials were discontinued due to endometrial changes in patients. Whether asoprisnil will be marketed is uncertain.
References
Asoprisnil Wikipedia(Text) CC BY-SA